Other Events ·
Nasdaq notifies company of non-compliance with the $1.00 minimum bid price
POMPOMDOCTOR Ltd
The Nasdaq Stock Market notified POMDOCTOR Limited that its American depositary shares closed below $1.00 per share for 30 consecutive business days, triggering a delisting determination from the Listing Qualifications Department. The company is ineligible for the standard 180-day compliance period because it executed a 1-for-18 reverse stock split on June 22, 2026. Securities are scheduled to be suspended from trading on October 15, 2026, unless an appeal is filed by the October 13 deadline. The company intends to request a hearing before a Nasdaq Hearings Panel to present a plan for regaining compliance, which will stay the suspension pending the panel's decision. POMDOCTOR Limited operates in the digital healthcare industry, focusing on AI-enabled solutions and predictive capabilities.